Cargando…
A unified multi‐activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS)
PURPOSE: Application of linear‐quadratic (LQ) model to large fractional dose treatments is inconsistent with observed cell survival curves having a straight portion at high doses. We have proposed a unified multi‐activation (UMA) model to fit cell survival curves over the entire dose range that allo...
Autores principales: | Li, Shidong, Miyamoto, Curtis, Wang, Bin, Giaddui, Tawfik, Micaily, Bizhan, Hollander, Andrew, Weiss, Stephanie E., Weaver, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248130/ https://www.ncbi.nlm.nih.gov/pubmed/33590493 http://dx.doi.org/10.1002/mp.14690 |
Ejemplares similares
-
Treatment of oligometastatic lung cancer with brain metastases using stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT)
por: Nikitas, John, et al.
Publicado: (2019) -
High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina
por: Beriwal, Sushil, et al.
Publicado: (2008) -
Esophageal tolerance to high-dose stereotactic radiosurgery
por: Lee, Bo Mi, et al.
Publicado: (2013) -
Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
por: Vempati, Prashant, et al.
Publicado: (2020) -
Plan Assessment Metrics for Dose Painting in Stereotactic Radiosurgery
por: Tham, Benjamin Z., et al.
Publicado: (2023)